Literature DB >> 1325988

Impaired corpus luteum function and other undesired results of pregnancies associated with inadvertent administration of a long-acting agonist of gonadotrophin-releasing hormone.

A Herman1, R Ron-El, A Golan, H Nachum, Y Soffer, E Caspi.   

Abstract

Spontaneous pregnancies associated with inadvertent periconceptional administration of long-acting gonadotrophin releasing-hormone agonist (GnRHa), in in-vitro fertilization, occurred in 11 of 161 patients with non-tubal infertility. All these cases exhibited impaired function of the corpus luteum in terms of declining progesterone levels, despite rising levels of human chorionic gonadotrophin. The patients were categorized according to the timing of GnRHa administration: periovulatory (three cases), midluteal (five cases) and late luteal (three cases). Altogether, of the 11 pregnancies, seven ended with a normal livebirth, three with a preclinical gestation and one with a blighted ovum. It appears that spontaneous pregnancies associated with inadvertent administration of GnRHa are not rare. Awareness for early diagnosis and close hormonal monitoring are recommended for the assessment of corpus luteum function and adequate supplementation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1325988     DOI: 10.1093/oxfordjournals.humrep.a137671

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  5 in total

Review 1.  Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis.

Authors:  João Batista A Oliveira; Ricardo Baruffi; Cláudia G Petersen; Ana L Mauri; Mario Cavagna; José G Franco
Journal:  Reprod Biol Endocrinol       Date:  2010-09-08       Impact factor: 5.211

Review 2.  Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles.

Authors:  Luiz Eduardo T Albuquerque; Leopoldo O Tso; Humberto Saconato; Maria Cecília R M Albuquerque; Cristiane R Macedo
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

3.  Comparison between depot leuprorelin and daily buserelin in IVF.

Authors:  E Porcu; M Filicori; L Dal Prato; R Fabbri; R Seracchioli; C Colombi; C Flamigni
Journal:  J Assist Reprod Genet       Date:  1995-01       Impact factor: 3.412

4.  Outcome of pregnancies inadvertently exposed to gonadotropin-releasing hormone analogues (GnRH-a) in early gestation.

Authors:  Y Gonen; M Dirnfeld; H Abramovici
Journal:  J Assist Reprod Genet       Date:  1993-08       Impact factor: 3.412

5.  GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial.

Authors:  Francesco M Fusi; Claudio M Brigante; Laura Zanga; Mario Mignini Renzini; Chiara Bosisio; Rubens Fadini
Journal:  Reprod Biol Endocrinol       Date:  2019-11-29       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.